Free Trial

Viking Therapeutics (VKTX) SEC Filings & 10K Form

$50.10
+0.26 (+0.52%)
(As of 07/18/2024 ET)

Recent Viking Therapeutics SEC Filings

DateFilerForm TypeView
06/04/2024
6:10 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
6:46 PM
Viking Therapeutics (Filer)
Form S-8 POS
05/22/2024
6:54 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
3:33 PM
Viking Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/03/2024
7:51 PM
Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
3:04 PM
Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
8:27 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
3:02 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/24/2024
7:42 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
3:05 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
3:15 PM
Viking Therapeutics (Filer)
Form ARS
03/27/2024
7:50 PM
Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:51 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:52 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:08 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
6:50 PM
Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:52 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:54 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:52 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
3:05 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
4:21 PM
Viking Therapeutics (Filer)
Form 424B5
02/27/2024
6:04 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
7:59 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
6:38 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
6:40 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
4:24 PM
Viking Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/07/2024
4:33 PM
Viking Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/31/2024
7:39 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:32 PM
Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
8:05 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:23 PM
Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
12:24 PM
STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
01/19/2024
7:35 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:36 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
3:26 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
01/04/2024
8:35 PM
Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:36 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:37 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:22 PM
FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:24 PM
MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:25 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
He called Nvidia at $8. Here’s his next pick … (Ad)

Michael has top-level access to pioneering tech CEOs, prize-winning scientists, military leaders and high-profile industry stalwarts. Right now, he’s all over artificial intelligence. And he knows what AI chip giant Nvidia is going to do next …

Find out more about Michael Robinson’s next big AI prediction
01/04/2024
8:27 PM
Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:28 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:12 PM
Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/02/2023
3:30 PM
VIKING GLOBAL INVESTORS LP (Filed by)
Viking Therapeutics (Subject)
Form SC 13G
10/25/2023
4:05 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2023
3:24 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VKTX) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners